Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02893371 · ClinicalTrials.gov registry record
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
A clinical trial, sponsored by University of New Mexico.
- Terminated
- Registry status
- 1,037,352
- Enrollment target
NCT02893371 is a clinical trial that was terminated before completion, run by University of New Mexico. The registered enrollment target is 1,037,352 participants.
The verdict
NCT02893371 was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- 1,037,352 participants
- Enrollment target
Study Summary
The objective of this retrospective observational study is to compare commonly prescribed bipolar disorder medications for their impact on: (1) hospitalization; (2) suicide attempts and self-harm; and (3) risk of drug-induced adverse effects such as kidney disease and diabetes mellitus. In addition, the investigators will examine heterogeneity of treatment effect by co-morbidity within pediatric, adult, and elderly sub-populations. Patient focus groups are convened to elicit additional questions and provide feedback on results.
Interventions
- DRUG Lamotrigine
- DRUG Oxcarbazepine
- DRUG Valproic Acid
- DRUG Carbamazepine
- DRUG Lithium Carbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,037,352 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02893371
The ClinicalTrials.gov registry entry for NCT02893371 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,037,352 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Lamotrigine is the first listed.
NCT02893371 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02893371 about?
NCT02893371 is a clinical study titled "Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies". The objective of this retrospective observational study is to compare commonly prescribed bipolar disorder medications for their impact on: (1) hospitalization; (2) suicide attempts and self-harm; and (3) risk of drug-induced adverse effects such as kidney disease and diabetes mellitus. In addition,...
What is the current status of trial NCT02893371?
This trial is currently terminated. The enrollment target is 1,037,352 participants. The study started on 2016-09. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT02893371?
The interventions under investigation include: Lamotrigine (DRUG), Oxcarbazepine (DRUG), Valproic Acid (DRUG), Carbamazepine (DRUG), Lithium Carbonate (DRUG).
Who is sponsoring clinical trial NCT02893371?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.